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Abstract 
Purpose: To estimate the prevalence and species of intestinal parasites in an Afghan community as 
well as to establish appropriate treatment method for each of the detected pathogens. 
Methods: Parasitological examination of stool samples collected from 777 children aged 1-17 years, 
treated in Ghazni Provincial Hospital (eastern Afghanistan) conducted in the period 2012 - 2013 made it 
possible to implement dedicated antiparasitic treatment.  
Results: Of 312 children (40.2 % of the examined group; p < 0.05) infected with nematodes (n = 154, 
19.7 %), cestodes (n = 90, 11.6 %), trematodes (n = 16, 2.1 %), and protozoa (n = 135, 17.4 %), 67 
were diagnosed with co-infections (mainly ascariasis + giardiasis, ascariasis + hymenolepiasis, 
giardiasis + hymenolepiasis, ascariasis + giardiasis + hymenolepiasis) and received complex therapy 
(albendazole + metronidazole, albendazole + praziquantel, metronidazole + praziquantel, and 
albendazole + metronidazole + praziquantel).  
Conclusion: Owing to high prevalence of multiple co-infections among inhabitants of the Afghan 
community, it seems that a mass deworming campaign with a single-dose chemotherapy (albendazole 
400 mg or mebendazole 500 mg) may prove ineffective in eradicating intestinal parasites in the local 
population.  
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The incidence of gastrointestinal infectious and 
invasive diseases in Afghanistan is exceptionally 
high, which is mainly influenced by soil and water 
contamination [1], a limited number of 
households obtaining drinking water from 
controlled sources and having improved 
sanitation facilities, a large number of 
asymptomatic carriers of contagious and 
parasitic diseases, and mass migration [2]. 
Owing to limited diagnostic capabilities of the 
Afghan health care, reports on the prevalence of 
diseases in the general population are rarely 
laboratory-confirmed. An improvement in the 
health status of the Afghan population is 
additionally restrained by poor public awareness 
of the principles of hygiene and disease 
prevention [3].  
 
It is estimated that the rates of bacterial and viral 
diarrheal illnesses as well as the prevalence of 
intestinal parasitic infections are high among 
inhabitants of Afghanistan. According to the U.S. 
Department of Defense, the rates of amebiasis in 
the general population reach 3 %, giardiasis has 
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been found in nearly 11 % of the surveyed 
children, and as much as 90 % of the population 
may be infected with at least one intestinal 
parasite [4]. The data, however, are only rough 
estimates based on the results of a few 
screening studies.  
 
The purpose of this study was to estimate the 
prevalence and species of intestinal parasites in 
the Afghan community as well as to establish 
appropriate treatment method for each of the 






Polish medical personnel serving in the 
International Security Assistance Force 
Operation in Afghanistan in cooperation with the 
Head of the Health Service Department in 
Ghazni Province Zia Ghul, MD and the Head of 
Ghazni Provincial Hospital (GPH) Baz 
Mohammat Hemmat, MD, surveyed 777 Afghan 
children aged 1-17 years, who were treated for 
internal complaints in Ghazni Provincial Hospital 





Three stool samples were collected from each 
patient (every second day), the samples were 
fixed in 10 % formalin, and transported to the 
Military Institute of Medicine in Poland, where 
they were tested by light microscopy using the 
methods of direct smear and decantation, both 
counterstained with Lugol’s solution as well as 
Fülleborn’s flotation technique. Each of the 
samples collected from every patient was tested 
by means of all three methods. Thus, a total of 




The diagnosis of intestinal parasites was 
performed by light microscopy using three stool-
testing methods [5] as follows: 
 
Direct smear in Lugol’s solution 
 
Approximately 2 mg of stool specimen was 
collected with a glass rod and applied onto a 
slide, a drop of Lugol’s solution was added and 
the material was smeared over a 4 cm2 surface. 
Next, a cover slide was placed on top of the 
preparation and the material was examined 
microscopically under x20 magnification.  
 
Preparation from decantation in distilled 
water 
 
Approximately 2 ml of stool specimen was mixed 
thoroughly with a small amount of water in a test 
tube. Next, water was added to the top of the 
tube and mixed again. After 30 min the 
supernatant was decanted and another portion of 
water was added. The procedure was repeated 
until clear supernatant was obtained, generally 
three to four times. The sediment was then 
placed on a slide and stained with Lugol’s 
solution for microscopic examination at x40 
magnification). 
 
Preparation from Fülleborn’s flotation 
 
Approximately 2 ml of stool specimen was mixed 
with saturated sodium chloride, NaCl solution in 
a test tube. Next, the NaCl solution was added to 
the top of the tube. A cover slide was placed 
gently on top of the tube and in contact with the 
suspension. After 30 minutes, the cover slide 
was gently removed with tweezers and placed 
the wet side down on a slide. The preparation 





Statistical analysis was performed using 
STATISTICA (data analysis software system) 
version 10.0 (SN JGNP3087539302AR-E) and 
Microsoft Excel 2010. The quantitative variables 
were characterized by the arithmetic mean of 
standard deviation or median or max/min (range) 
and 95 % confidence interval. The qualitative 
variables were presented with the use of count 
and percentage. Statistical significance of 
differences between two groups (unpaired 
variables model) was processed with the t-
Student test (or Welch test in the case of lack of 
homogeneity) or Mann-Withney U test (in cases 
where conditions of performing the t-Student test 
were not satisfied or for variables measured by 
ordinal scale). Chi-squared tests for 
independence were used for qualitative 
variables. In order to determine dependence, 
strength and direction between variables, 
correlation analysis was used by determining the 
Pearson or Spearman’s correlation coefficients. 
In all the calculations the statistical significance 




The mean age in the study population of 777 
Afghan children treated in Ghazni Provincial 
Hospital was 8.7 years (range 1-17). The mean 
age of females was 8.7 and males 9.0 (range 1-
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17). The analysis of age and sex did not show 
statistically significant differences (Mann-Whitney 
U test 1.28, p = 0.2018). The mean age of 
children without infections was 8.7 and children 
with infections was 9.2 (range 1-17). The 
analysis of age and infection rates did not show 
statistically significant differences (Mann-Whitney 
U test 1.43, p = 0.1533). There were 296 (38.1 
%) females and 481 (61.9 %) males in the study 
group. Infections were confirmed in 312 children 
(40.2 %) -106 females (34.0 %) and 206 males 
(66.0 %). 
 
Parasitological examination, which revealed that 
40.2 % of the children treated in GPH in eastern 
Afghanistan were infected with pathogenic 
intestinal parasites, and another 35.0 % with 
non-pathogenic protozoa [6], helped implement 
appropriate treatment in line with current 
standards of the antiparasitic therapy [7]. Of the 
312 children infected with nematodes (154, 19.7 
%), cestodes (90, 11.6 %), trematodes (16, 2.1 
%), and protozoa (135, 17.4 %), 67 were 
diagnosed with co-infections (mainly ascariasis + 
giardiasis; ascariasis + hymenolepiasis; 
giardiasis + hymenolepiasis; ascariasis + 
giardiasis + hymenolepiasis) and received 
complex therapy (albendazole + metronidazole; 
albendazole + praziquantel; metronidazole + 
praziquantel; albendazole + metronidazole + 
praziquantel) (Table 1). 
 
There were some statistically significant 
differences in the distribution of the types of 
intestinal parasites among the infected children 
(p < 0.001). The most common species were 
nematodes and protozoa (see Table 1). 
 
The percentage of infections among males was 
significantly higher than among infected females 
(p = 0.0324). The analysis of the rates of 
infections with intestinal parasites among 
children by sex did not show any statistically 
significant differences (Figure 1). 
 






% Infected  
children(n=
312) 




Nematodes 154 49.4 19.7 p<0.001  
Ascarislumbricoides 134 42.9 17.2 p<0.001 Albendazole 
Enterobiusvermicularis 17 5.4 2.2 p=0.001 Albendazole 
Strongyloidesstercoralis 2 0.6 0.3 p=0.001 Albendazole 
Ancylostomaduodenale/ 
Necatoramericanus 1 0.3 0.1 p=0.001 Albendazole 
Cestodes 90 28.8 11.6 p=0.001  
Hymenolepis nana 64 20.5 8.2 p=0.001 Praziquantel 
Hymenolepisdiminuta 20 6.4 2.6 p=0.001 Praziquantel 
Taenia spp. 6 1.9 0.8 p=0.001 Praziquantel 
Trematodes 16 5.1 2.1 p=0.001  
Dicrocoeliumdendriticum 11 3.5 1.4 p=0.001 Praziquantel 
Fasciola hepatica 5 1.6 0.6 p=0.001 Triclabendazole 
Protozoa 135 43.3 17.4 p<0.001  
Giardia intestinalis 130 41.7 16.7 p<0.001 Metronidazole 
Entamoeba histolytica 5 1.6 0.6 p=0.001 Metronidazole 




           Figure 1: Distribution of parasitic infections in Afghan children by sex 
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1 4 (2.6) 3 (3.3) 0 (0.0) 2 (1.5) 9 (2.3) 
2 1 (0.6) 0 (0.0) 0 (0.0) 2 (1.5) 3 (0.8) 
3 3 (1.9) 4 (4.4) 1 (6.3) 6 (4.4) 14 (3.5) 
4 4 (2.6) 7 (7.8) 0 (0.0) 10 (7.4) 21 (5.3) 
5 6 (3.9) 5 (5.6) 0 (0.0) 7 (5.2) 18 (4.6) 
6 10 (6.5) 7 (7.8) 0 (0.0) 10 (7.4) 27 (6.8) 
7 8 (5.2) 5 (5.6) 2 (12.5) 11 (8.1) 26 (6.6) 
8 15 (9.7) 9 (10.0) 3 (18.8) 19 (14.1) 46 (11.6) 
9 16 (10.4) 8 (8.9) 3 (18.8) 11 (8.1) 38 (9.6) 
10 20 (13.0) 10 (11.1) 3 (18.8) 14 (10.4) 47 (11.9) 
11 17 (11.0) 5 (5.6) 1 (6.3) 8 (5.9) 31 (7.8) 
12 15 (9.7) 7 (7.8) 1 (6.3) 12 (8.9) 35 (8.9) 
13 10 (6.5) 4 (4.4) 1 (6.3) 7 (5.2) 22 (5.6) 
14 9 (5.8) 8 (8.9) 1 (6.3) 7 (5.2) 25 (6.3) 
15 8 (5.2) 3 (3.3) 0 (0.0) 3 (2.2) 14 (3.5) 
16 4 (2.6) 3 (3.3) 0 (0.0) 5 (3.7) 12 (3.0) 
17 4 (2.6) 2 (2.2) 0 (0.0) 1 (0.7) 7 (1.8) 
 
Detailed information on the numbers and rates of 
intestinal parasites by age of the infected 
children is presented in Table 2. The analysis of 
the distribution of parasitic infections among 
Afghan children by age did not show any 
statistically significant differences (Chi2test 
29.97, p = 0.9807). 
 
The analysis of the distribution of parasitic 
infections among males did not show statistically 
significant differences (Chi2test 39.97, p = 
0.7885), the same applied to infected females 
(Chi2test 48.15, p = 0.4666). 
 
The analysis of the relationship between age and 
number of infections among children did not 
show statistically significant differences, both in 
males (R = 0.26, p = 0.3070) and females (R = 
0.24, p = 0.3530). 
 
The relationship between children’s age/sex and 
the rates of parasitic infections was also 
examined.  The results of univariate and 
multivariate regression did not show statistically 
significant relationship between age, sex and 




The Afghan community, living in poor 
socioeconomic conditions and having a limited 
access to health care, is an example of a 
population characterized by a high rate of 
parasitic infections. In February and March 2003, 
the United Nations World Food Programme 
(WFP), in cooperation with the World Health 
Organization (WHO) and the Afghan Ministries of 
Health and of Education, conducted a cross-
sectional parasitological examination in a group 
of 1001 children aged 8-15 from four Afghan 
provinces (Kabul, Nangarhar, Farah, Kandahar). 
The survey revealed the presence of intestinal 
parasites in 47.2 % of the examined children. 
The most common pathogen was Ascaris 
lumbricoides, detected in 40.9 % of the 
population under study. The authors of the 
survey suggested that regular administration of 
single-dose chemotherapy (albendazole 400 mg 
or mebendazole 500 mg) would be a cost-
effective method of controlling soil-transmitted 
helminth infections at the public health level [8]. 
In September 2004, WFP announced that the 
deworming campaign which had started six 
months before involved more than 4.5 million 
school children aged 6-12 living in Afghanistan. 
The children were given a single oral dose of 
mebendazole. The total cost of deworming was 
approximately US$ 0.10 per child [9]. WHO 
recommends annual mass antihelminthic 
treatment of all school-age children in areas 
where the prevalence is >20 % or twice a year 
when the prevalence is >50 %, with the goal of 
preventing adverse effects on nutritional status, 
hemoglobin concentration and cognition in order 
to improve health, intellect and school 
attendance [10]. Improvements in sanitation and 
health education are also important interventions 
required in order to change practices and 
behaviors that reduce the transmission of 
intestinal parasites [11,12].  
 
Preventive chemotherapy represents a powerful 
but short-term control strategy for parasitic 
infections of the gastrointestinal tract. Since 
humans are often re-infected rapidly, long-term 
solutions require improvements in water, 
sanitation, and hygiene (WASH). WASH 
interventions are diverse, potentially including 
improvements in water access (e.g., water 
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quality, water quantity, and distance to water), 
sanitation access (e.g., access to improved 
latrines, latrine maintenance, and fecal sludge 
management), and hygiene practices (e.g., 
handwashing before eating and after defecation, 
water treatment, soap use, wearing shoes, and 
water storage practices) [13]. 
 
Most mass deworming programs have been 
school-based because children tend to have the 
highest prevalence and intensity of infection [14]. 
The programs focus on geographic areas with a 
high prevalence, using drugs recommended by 
the WHO [15]. Effective chemotherapy includes 
mainly the use of mebendazole or albendazole, 
and occasionally pyrantel pamoate or levamisole 
in the intestinal nematode treatment [16]. 
However, the large-scale administration of 
antihelminthics might result in the development 
and spread of drug resistant nematodes [17], 
which is already a significant problem in 
veterinary medicine [18]. Selected studies 
pointed, that the administration of a single dose 
of mebendazole lacked efficacy against 
hookworm infections among schoolchildren in 
Zanzibar [19] and Vietnam [20]. Keiser and 
Utzinger [17] reported high cure rates of single 
dose mebendazole and albendazole for Ascaris 
lumbricoides (90 %) and low cure rates in the 
same dose of mebendazole for Trichuris trichiura 
(36 %) and hookworm (15 %). In Rwanda, a 
national survey among more than 8000 
schoolchildren in 30 districts found an overall soil 
transmitted helminths prevalence of 66 %. A 
repeat survey conducted one year after the 
standard deworming found a reduction in 
ascariasis and trichuriasis prevalence by 14 %, 
and increase in hookworm prevalence by 72 % 
[21]. 
 
The central element in the global strategy of 
intestinal parasites control is preventive, 
repeated chemotherapy. Regular treatment aims 
at reducing the parasites burden below threshold 
associated with morbidity. The successful efforts 
to reduce morbidity in local population needed to 
be supplemented by more integrated and 
multisectoral approach to public health [16]. This 
human development agenda was the prime 
motivation for the highly successful national 
deworming program in South Korea. National 
surveys on the prevalence of intestinal parasitic 
infections in the Korean population have been 
carried out every 5-7 years since 1971 in order to 
establish control measures. The first survey 
conducted in 1971, showed an overall helminth 
egg positive rate of 84.3 % among Korean 
people. During the subsequent 30 years, Korea 
showed very high economic growth with a 
dramatic decrease of the helminth egg positive 
rate down to 2.4 % in 1997. In particular, A. 
lumbriocoides showed a decrease from 54.9 % in 
1971 to 0.06 % in 1997. Other soil-transmitted 
helminths also presented decreases in the 
prevalence down to 0.007 % for hookworms and 
0.04 % for T. trichiura [22]. 
 
World Health Organization gave greater 
emphasis to deworming in specific age groups, 
especially pre-school children, school age 
children, and women of reproductive age, and in 
2001 the World Health Assembly declared the 
goal of ensuring that 75 % of all school age 
children in endemic areas should receive 
treatment. Pharmaceutical companies have 
donated treatment specifically for deworming of 
school children: with 50 mg mebendazole 
treatments a year from Johnson & Johnson in 
2007, rising to 200 mg in 2010, and 400 mg 
treatments of albendazole from GlaxoSmithKline 
in 2012. These donations have had broad 
impact, increasing the cost-effectiveness of 
deworming and heightening the attractiveness of 
deworming programs within public health 
systems [16]. The large donation of 600 million 
doses per year announced in the London 
Declaration (a declaration on neglected tropical 
diseases was based in part on a new WHO 
roadmap in UK in 2012) almost completely 
covers the estimated 610 million school aged 
children in need of preventive chemotherapy [23, 
24], but it does not cover pre-school children, 
women of child-bearing age or treatments more 
than once a year [25]. 
 
Unfortunately, deworming campaigns launched 
in the Third World countries of the Middle East 
and Central Asia in the last years have not been 
successful. In 2011, only 0.69 % school age 
children in the Eastern Mediterranean Region 
(including Afghanistan) received preventive 
antiparasitic therapy (albendazole or 
mebendazole) [26]. One of the main reasons why 
such campaigns end in failure is unstable 
geopolitical situation in the region, as is the case 
with Afghanistan, where humanitarian aid is 
provided mainly by the international coalition 
forces stationing in the country since 2001. One 
of the participants in the International Security 
Assistance Force operation in Afghanistan was 
the Polish Military Contingent (PMC), which 
carried out its mandatory tasks in Ghazni 
Province in eastern part of the country in the 
period 2008-2014. One of the components of the 
PMC was a medical unit whose task was to 
provide treatment and prophylaxis among the 
local population. Polish military physicians not 
only treated war casualties, but also diagnosed 
and treated infectious and invasive diseases. In 
March and September 2012, two conferences 
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were organized in the Ghazni Governor’s office; 
they were attended by Afghan health care 
workers and focused on the contemporary 
epidemiological situation and the prevalence of 
communicable diseases in Afghanistan, including 
intestinal parasitic infections. In March 2013, 
medical personnel from PMC Afghanistan 
designed and implemented the project Capacity 
building of health care system in Ghazni 
Province (financed by the Polish Ministry of 
National Defence). One of the aims of this project 
was to purchase thousands of medicine doses 
(albendazole, metronidazole, praziquantel) for 
the infected children treated in Ghazni Provincial 
Hospital (tested in the period March 2012 - 
March 2013), as well as for the infected pupils 
from the Jahan Malika High School (tested in the 
period November 2013 - April 2014) [27] in the 
capital of Ghazni Province. The cost of 
deworming was about 22 afghani (US$ 0.35) per 
child. Given large differences in medicine prices 
between developing and developed countries 
(the cost of a single dose of albendazole or 
metronidazole is over US$ 5 in Europe and 
USA), the decision was taken to carry out 
pharmaceutical tests on the compliance of the 
medicine samples with the requirements for the 
products. The samples were tested in the Official 
Medicines Control Laboratory of the National 
Medicines Institute in Warsaw, Poland. The 
investigated parameters of Flagyl 
(metronidazole) 200 mg and 400 mg tablets 
(Sanofi-Aventis Pakistan Ltd., Korangi Industrial 
Area, Karachi), and Zentel (albendazole) 200 mg 
tablets (GlaxoSmithKline Pakistan Ltd., F/268 
S.I.T.E., Karachi) were in compliance with the 
requirements of the British Pharmacopoeia 2012, 
the United States Pharmacopeia 36, and the 
European Pharmacopoeia 8th Edition as regards 
identification, active ingredient content and 
chemical purity of the product.  
 
Owing to high prevalence of multiple infections 
(nematodes, cestodes, trematodes, protozoa) in 
the Afghan community, it seems that a mass 
deworming campaign with a single-dose 
chemotherapy (albendazole 400 mg or 
mebendazole 500 mg) may prove ineffective in 
eradicating intestinal parasites in the local 
population. The effectiveness of deworming may 
be enhanced by increasing the dosage of 
albendazole (400 mg for three-five days) [28,29] 
or mebendazole (600 mg for three days) [30] or 
usage of complex therapy (albendazole 400 mg 
one dose, metronidazole 250 mg three times 
daily for five days, praziquantel 5-25 mg/kg one 
dose), which, considering the low cost of the 
medications, seems an acceptable form of the 
antiparasitic therapy. 
 
Limitation of the study 
 
The major limitation of this study is the 2 - 4 
week period between the collection of stool 
samples in Ghazni Provincial Hospital in 
Afghanistan and the examinationof fixed 




Owing to high prevalence of multiple co-
infections (ascariasis, giardiasis, hymenolepiasis) 
among inhabitants of Afghanistan, it seems that 
a mass deworming campaign aiming at 
eradicating intestinal parasites in the local 
population should be enhanced by increasing the 
dosage of albendazole or mebendazole or usage 
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